Tempus Now an In-Network Provider for Blue Cross Blue Shield Illinois, Blue Shield California, and Avalon Healthcare Solutions
New CMS Decision Provides Medicare Coverage for the Clinical Use of the Tempus ECG-AF Device [Yahoo! Finance]
Why Healthcare Providers Are Increasingly Trusting Artificial Intelligence for Detection & Diagnosis
New CMS Decision Provides Medicare Coverage for the Clinical Use of the Tempus ECG-AF Device
Tempus AI, Inc. (NASDAQ: TEM) had its price target raised by analysts at Bank of America Co. from $52.00 to $54.00. They now have a "neutral" rating on the stock.